MISSISSAUGA, ON, Jan. 18 /CNW/ - YM BioSciences Inc. (AMEX:YMI, TSX:YM,
AIM:YMBA), an oncology company that identifies, develops and commercializes
differentiated products for patients worldwide, today announced that it has
been notified that Accipiter Life Sciences Fund, LP and affiliated funds now
hold 3,497,795 Common Shares in the Company.
